CCR2 and glomerulonephritis: Naotoshi Kanemitsu et al. showed that the glutaminyl cyclase (QC)/isoQC inhibitor PQ529 could inhibit the CCL2/CCR2 axis to suppress the progression of renal dysfunction in rats with glomerulonephritis [25].